Physician

John F Payne, MD

According to 2025 Medicare claims, John Payne, MD (NPI: 1528143021) practices ophthalmology in the Columbia, SC market, with the plurality of this provider's patient population coming from Lexington, SC. This provider's primary affiliated billing organization is PALMETTO RETINA CENTER LLC (NPI: 1255322806; TIN: 57-0955585) and primary practice location at 29169-2429. Payne is affiliated with the CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under the REACH model.

Payne's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 765 traditional Medicare patients, billed 27,337 HCPCS/CPT codes, and received $4,076,040 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 702 prescription claims across 195 beneficiaries totaling $38,733 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 17 records totaling $114,143. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.4M$4.8M2015 Medicare payment: $2,743,080 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,720,253 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $4,292,737 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $4,388,974 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,593,377 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $4,515,213 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,758,284 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,845,374 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,085,348 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,076,040 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201585111,994$2,743,080
201688714,977$3,720,253
201789416,720$4,292,737
201892617,653$4,388,974
201993818,866$4,593,377
202085618,675$4,515,213
202190920,401$4,758,284
202282917,274$3,845,374
202380524,711$4,085,348
202476527,337$4,076,040

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$37K$75K2015 Drug cost: $42,974 (USD; Tot_Drug_Cst)2016 Drug cost: $41,991 (USD; Tot_Drug_Cst)2017 Drug cost: $64,855 (USD; Tot_Drug_Cst)2018 Drug cost: $54,706 (USD; Tot_Drug_Cst)2019 Drug cost: $50,104 (USD; Tot_Drug_Cst)2020 Drug cost: $68,544 (USD; Tot_Drug_Cst)2021 Drug cost: $74,025 (USD; Tot_Drug_Cst)2022 Drug cost: $74,601 (USD; Tot_Drug_Cst)2023 Drug cost: $56,027 (USD; Tot_Drug_Cst)2024 Drug cost: $38,733 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015195707$42,974
2016196672$41,991
2017211905$64,855
2018256916$54,706
2019211828$50,104
2020203811$68,544
20212571,010$74,025
2022246923$74,601
2023207771$56,027
2024195702$38,733

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg3354,564$656
67028Injection of drug into eye3922,120$96
92014Established patient complete exam of visual system327425$84
92012Established patient problem focused exam of visual system339537$59
92134Imaging of retina7382,799$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate2098,405$10,663
CombiganBrimonidine Tartrate/Timolol18664$5,438
DifluprednateDifluprednate27607$4,016
Atropine SulfateAtropine Sulfate552,195$2,090
Brimonidine TartrateBrimonidine Tartrate782,430$1,437

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$223ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.9$113,920Ocular Therapeutix, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John F. Payne, MD?

Tedicare shows public-source Medicare data for John F. Payne, MD (NPI 1528143021), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John F. Payne, MD have ACO affiliation data?

John F. Payne, MD is shown with ACO affiliation data for CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to John F. Payne, MD?

John F. Payne, MD is linked to PALMETTO RETINA CENTER LLC (billing NPI 1255322806) in the available physician profile data.

Does John F. Payne, MD have Open Payments data?

John F. Payne, MD has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.